Elilily释放了新的Zepbound剂量 调整了价格 使减重药物更便宜 Eli Lilly releases new Zepbound doses, adjusts pricing to make weight-loss drug more affordable.

Eli Lilly引入了新的7.5毫克和10毫克小瓶剂量的减重药物Zepbound,每月价格为499美元。 Eli Lilly has introduced new 7.5 mg and 10 mg vial doses of the weight-loss drug Zepbound, priced at $499 per month. 该公司还降低了2.5毫克和5毫克小瓶的价格,目的是通过其LillyDirect平台使自付费用的病人更容易获得这种药物。 The company has also lowered the price of 2.5 mg and 5 mg vials, aiming to make the drug more accessible to self-pay patients through its LillyDirect platform. 模仿内分泌激素以减少食欲的Zepbound现在以较低的价格提供,以便与其他减重药品竞争,并解决人们负担得起的问题。 Zepbound, which mimics gut hormones to reduce appetite, is now offered at reduced prices to compete with other weight-loss medications and address affordability concerns.